BioPorto A/S
BIOPOR
Rangering i aksjer
#22971
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Aksjekurs
$0.15400149
Sist synkronisert: 2026-10-21
Markedsverdi
$76.25M
Endring (1 dag)
-5.83%
Endring (1 år)
-46.53%
Land
DK
Handel BioPorto A/S (BIOPOR)
Kategori
Healthcare
Aksjeprishistorikk for BioPorto A/S (BIOPOR)
Høyeste sluttskurs: $0.15 den 2026-10-01
Laveste sluttskurs: $0.41 den 2019-12-01
Laveste sluttskurs: $0.41 den 2019-12-01
Aksjeprishistorikk for BioPorto A/S fra 2019 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | -35.46% |
| 2025 | 0.00% |
| 2024 | -28.16% |
| 2023 | -37.74% |
| 2022 | -14.14% |
| 2021 | 106.94% |
| 2020 | -11.60% |
| 2019 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $22.06 | 55.84% |
CN
|
|
| $177.93 | 21.98% |
US
|
